We're on a Mission to Accelerate Precision Medicine

Chris Capdevila, Chief Executive Officer   

As Chief Executive Officer at Amplion, Chris brings over 25 years of experience in leading enterprise software companies to success, including LogicalApps, Oracle, and Fiserv.

Chris is deeply passionate about the paradigm shift that we are experiencing in drug development and the inevitable realization of precision medicine. He understands the challenges that this fundamental paradigm shift brings to our Life Science customers and firmly believes that the power of machine learning will unlock the efficiencies and discoveries that are absolutely critical to success in precision medicine.

Chris graduated summa cum laude from UCLA with a Bachelor of Science degree in Economics and was named Software Entrepreneur of the Year in 2005 by the California Software Council.

Adam Carroll, Ph.D., Chief Science Officer   

As Chief Science Officer at Amplion, Adam uses his 25 years of experience in biomedical and data science to develop the Deep Learning models that power our Biomarker Intelligence platform.

Adam believes deeply in the power of data analysis to improve human health and derives the greatest joy from managing interdisciplinary teams to achieve results that would be impossible otherwise.

Prior to founding Amplion, Adam was a Director at Bend Research (now part of Lonza) where he ran technology development programs in several areas, including nanoparticle drug delivery and biotherapeutic production, as well as led the team that built the activity quantifying algorithms in the Nike FuelBand.

Adam was an Assistant Adjunct Professor at UCSF, where he ran the Center for Advanced Technology. And he earned a PhD at UCSF in Biochemistry and Molecular Biology and a BA in Chemistry at Williams College.

Amanda Enstrom, Ph.D., Chief Product Officer   

As Chief Product Officer at Amplion, Amanda brings 20 years of experience in biomedical R&D, including supporting drug discovery across all phases of development.

Amanda believes that new approaches to standardized data handling, data mining, and data visualization techniques can accelerate precision medicine. Her passion for the field of Immuno-Oncology dates back to her doctoral work in combinatorial peptide library approaches to synthetic antibodies, but her specific interest is in bringing biomarkers from early development into validated clinical use using integrated data analysis and cross-platform biomarker discovery. 

Prior to joining Amplion, Amanda served as the Senior Director, R&D at Tempest Therapeutics, as a Director at Aduro Biotech, as a Senior Scientist at Bavarian Nordic, and as a Project Scientist at UC Davis Medical Center. 

Amanda taught biology for 7 years as a faculty member at CSU Sacramento. And she earned a PhD in Immunology from UC Davis.

Mike Harrington, Chief Technology Officer   

Mike Harrington joined Amplion as Chief Technical Officer in 2018 bringing 24 years of experience that spans several successful tech companies, startups and non-profit organizations. His experience includes Microsoft and Google, co-founding Valve Software and Picnik, and working with NetHope on disaster relief.

Most recently, Mike was the CTO for the industry leading provider of Social Emotional curriculum, Committee for Children. A leader in technology strategy, Harrington brings a strong engineering, leadership, and entrepreneurial experience to Amplion.

Michael Taus, Chief Marketing Officer   

As Chief Marketing Officer at Amplion, Michael brings over 20 years of experience in growing SaaS and software companies across a range of industries and functional roles. 

Michael believes that elegant products inspired by a powerful mission can drive meaningful impact for individuals and our communities. 

Prior to joining Amplion, Michael led marketing, business development and product teams at several high-growth companies, including Abodo, CrowdStreet, Profit Point and Rent.com. He is an insatiable entrepreneur who  has advised and mentored dozens of startup founders and CEOs. Michael earned a BA in Psychology from UC Irvine and a JD from McGeorge School of Law.

Tim Riefke, Chief Financial Officer   

As the Chief Financial Officer at Amplion, Tim manages the company’s Finances and oversees the Human Resources and Legal functions.

Tim brings a broad financial skillset, including experience in private equity, consulting, corporate finance and nonprofit management. Over the years he has worked with dozens of early- and growth-stage startups, including some of the most well funded tech startups in Oregon.

Tim graduated from the University of Wisconsin – Madison with a Bachelor of Science degree in Economics. He also holds a Chartered Financial Analyst designation.

Trey Knollman, Vice President - Sales

Trey joined the Amplion team in November of 2019 and brings 8 years of Sales and Management expertise in high-performing, technical teams working in life science research, pharmaceutical development, and diagnostics. Trey is passionate about identifying drug discovery, development, and commercialization workflow needs and delivering cutting-edge solutions that far exceed expectations. Prior to joining Amplion, Trey held Sales leadership roles at IsoPlexis, Sartorius, IntelliCyt, and Essen BioScience. Trey graduated from the University of Oregon with Biology and Chemistry Bachelor of Science degrees and lives in Seattle, WA.